Literature DB >> 17594715

Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alström syndrome.

Jan D Marshall1, Elizabeth G Hinman, Gayle B Collin, Sebastian Beck, Rita Cerqueira, Pietro Maffei, Gabriella Milan, Weidong Zhang, David I Wilson, Tom Hearn, Purificação Tavares, Roberto Vettor, Caterina Veronese, Mitchell Martin, W Venus So, Patsy M Nishina, Jürgen K Naggert.   

Abstract

Alström syndrome is a monogenic recessive disorder featuring an array of clinical manifestations, with systemic fibrosis and multiple organ involvement, including retinal degeneration, hearing loss, childhood obesity, diabetes mellitus, dilated cardiomyopathy (DCM), urological dysfunction, and pulmonary, hepatic, and renal failure. We evaluated a large cohort of patients with Alström syndrome for mutations in the ALMS1 gene. In total, 79 disease-causing variants were identified, of which 55 are novel mutations. The variants are primarily clustered in exons 8, 10, and 16, although we also identified novel mutations in exons 12 and 18. Most alleles were identified only once (45/79), but several were found recurrently. Founder effects are likely in families of English and Turkish descent. We also identified 66 SNPs and assessed the functional significance of these variants based on the conserved identity of the protein and the severity of the resulting amino acid substitution. A genotype-phenotype association study examining 18 phenotypic parameters in a subset of 58 patients found suggestive associations between disease-causing variants in exon 16 and the onset of retinal degeneration before the age of 1 year (P = 0.02), the occurrence of urological dysfunction (P = 0.02), of DCM (P = 0.03), and of diabetes (P = 0.03). A significant association was found between alterations in exon 8 and absent, mild, or delayed renal disease (P = 0.0007). This data may have implications for the understanding of the molecular mechanisms of ALMS1 and provides the basis for further investigation of how alternative splicing of ALMS1 contributes to the severity of the disease. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594715     DOI: 10.1002/humu.20577

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  69 in total

1.  Alström Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity.

Authors:  Daniel Jagger; Gayle Collin; John Kelly; Emily Towers; Graham Nevill; Chantal Longo-Guess; Jennifer Benson; Karin Halsey; David Dolan; Jan Marshall; Jürgen Naggert; Andrew Forge
Journal:  Hum Mol Genet       Date:  2010-11-11       Impact factor: 6.150

2.  A novel ALMS1 splice mutation in a non-obese juvenile-onset insulin-dependent syndromic diabetic patient.

Authors:  May Sanyoura; Cédric Woudstra; George Halaby; Patrick Baz; Valérie Senée; Pierre-Jean Guillausseau; Pierre Zalloua; Cécile Julier
Journal:  Eur J Hum Genet       Date:  2013-05-08       Impact factor: 4.246

Review 3.  Clinical screening and genetic testing.

Authors:  Rahul C Deo; Calum A MacRae
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

4.  Clinical utility gene card for: Alström syndrome.

Authors:  Jan D Marshall; Pietro Maffei; Sebastian Beck; Timothy G Barrett; Richard B Paisey
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

5.  Alström Syndrome: Mutation Spectrum of ALMS1.

Authors:  Jan D Marshall; Jean Muller; Gayle B Collin; Gabriella Milan; Stephen F Kingsmore; Darrell Dinwiddie; Emily G Farrow; Neil A Miller; Francesca Favaretto; Pietro Maffei; Hélène Dollfus; Roberto Vettor; Jürgen K Naggert
Journal:  Hum Mutat       Date:  2015-05-18       Impact factor: 4.878

Review 6.  Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity.

Authors:  Francesca Dassie; Francesca Favaretto; Silvia Bettini; Matteo Parolin; Marina Valenti; Felix Reschke; Thomas Danne; Roberto Vettor; Gabriella Milan; Pietro Maffei
Journal:  Endocrine       Date:  2021-02-10       Impact factor: 3.633

7.  Long-term clinical follow-up and molecular testing for diagnosis of the first Tunisian family with Alström syndrome.

Authors:  Amine Chakroun; Mariem Ben Said; Amine Ennouri; Imen Achour; Mouna Mnif; Mohamed Abid; Abdelmonem Ghorbel; Jan D Marshall; Jürgen K Naggert; Saber Masmoudi
Journal:  Eur J Med Genet       Date:  2016-08-12       Impact factor: 2.708

8.  Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731.

Authors:  Victoria J Knorz; Cosma Spalluto; Mark Lessard; Tracey L Purvis; Fiona F Adigun; Gayle B Collin; Neil A Hanley; David I Wilson; Thomas Hearn
Journal:  Mol Biol Cell       Date:  2010-09-15       Impact factor: 4.138

Review 9.  Nephronophthisis.

Authors:  Rémi Salomon; Sophie Saunier; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

10.  Impaired IGF1-GH axis and new therapeutic options in Alström Syndrome patients: a case series.

Authors:  Cristina Maria Mihai; Doina Catrinoiu; Marius Toringhibel; Ramona Mihaela Stoicescu; Negreanu-Pirjol Ticuta; Hancu Anca
Journal:  Cases J       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.